Edora 8 DR-T
Device Cardiology/Vascular Diseases
PDI 04035479147648
General payments
$1,372,579
Research payments
$69,152
Through program year 2024, $1,372,579 in general payments and $69,152 in research payments were reported against Edora 8 DR-T (Cardiology/Vascular Diseases).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $211,994 | 71 |
| 2023 | General | $236,439 | 838 |
| 2022 | General | $924,146 | 4,075 |
| 2022 | Research | $69,152 | 13 |
Breakdown
The top 5 of 53 recipients; each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 20 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
4,984 general · 13 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.